COL6A3 as a New Therapeutic Target in Recurrent Meningioma
Credit
KU Medicine
Usage Restrictions
none
License
Original content
Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.